ABBV stock, with 24% returns since the beginning of 2024, has marginally underperformed the S&P 500 index, up 27%. An increased competition and a mid-stage clinical trial failure for schizophrenia treatment last year are some of the factors that have weighed on its stock price growth lately.

SHOP's fourth-quarter 2024 performance is expected to reflect benefits from the growing adoption of merchant-friendly solutions.

Meta Platforms (NASDAQ: META) has been on a 10-day rally and gained 14% so far. This is the longest streak since 2015. META stock now trades at around $700. Shares were cratering back in 2022 due to Meta Platforms investing in its Reality Labs segment,

The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 billion and $1.79, respectively.